![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » Vyteris completes merger with MediSync BioServices
Vyteris completes merger with MediSync BioServices
April 19, 2011
New Jersey-based drug delivery company Vyteris has merged with MediSync BioServices, a company focused on consolidating CROs. MediSync has become a fully-owned subsidiary of Vyteris.
Haro Hartounian, CEO at Vyteris, said: “MediSync's current and possible future operations intend to potentially serve a growing demand for outsourced clinical research and related services as drug and medical device developers may be attracted to the efficiency and flexibility.”
Upcoming Events
-
21Oct